Rhinospray Eucalyptus nasal spray

Rhinospray is a long-standing brand in the nasal care category, renowned for its effectiveness in relieving nasal congestion. Originally developed in Germany, the brand incorporates active ingredients such as tramazoline and often features eucalyptus for a refreshing experience.

Historically part of the Boehringer Ingelheim consumer healthcare portfolio, the brand was transitioned to the French multinational healthcare company Sanofi as part of a significant asset swap in 2017. Manufacturing typically takes place at specialized pharmaceutical sites, primarily in Germany, to ensure high medical standards. Today, Rhinospray remains a key product in Sanofi's global Consumer Healthcare division, which is being prepared for a potential spinoff to enhance its focus on over-the-counter medical solutions.